Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

First-morning urine osmolality changes in children with nocturnal enuresis at the end of treatment

  • Yun Ha Lee (Department of Urology, Pusan National University Yangsan Hospital) ;
  • Jae Min Chung (Department of Urology, Pusan National University Yangsan Hospital) ;
  • Sang Don Lee (Department of Urology, Pusan National University Yangsan Hospital)
  • Received : 2024.01.03
  • Accepted : 2024.02.13
  • Published : 2024.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The ability to concentrate urine becomes an important index in determining nocturnal enuresis (NE) treatment. The aim of our study was to investigate first-morning urine osmolality (Uosm) changes at the end of treatment compared to before treatment in children with NE. Methods: A total of 71 children with NE were divided into two groups according to the level of first-morning Uosm before treatment: high group (≥800 mOsm/kg) and low group (<800 mOsm/kg). Baseline parameters were obtained from uroflowmetry, frequency volume charts for at least 2 days, and a questionnaire for lower urinary tract symptoms. All patients were basically treated with standard urotherapy and medication. The first-morning Uosm was measured twice, before treatment and at the end of treatment. Results: The response rate was higher in the low group after 3 months of treatment than in the high group (P=0.041). However, there was no difference between the two groups at the end of the treatment. In the high group, the first-morning Uosm at the end of treatment did not show a significant change compared to before treatment. In contrast, the first-morning Uosm increased in the low group at the end of treatment (P<0.001). However, it was still lower than that of the high group (P=0.007). Conclusions: The ability to concentrate nocturnal urine improved at the end of treatment compared to before treatment in the low Uosm NE children. In addition, NE improved faster in the low Uosm group before treatment than in the high group.

Keywords

Acknowledgement

This study was supported by a 2023 research grant from Pusan National University Yangsan Hospital.

References

  1. Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn 2016;35:471-81. https://doi.org/10.1002/nau.22751
  2. Chung JM, Lee SD, Kang DI, Kwon DD, Kim KS, Kim SY, et al. An epidemiologic study of voiding and bowel habits in Korean children: a nationwide multicenter study. Urology 2010;76:215-9. https://doi.org/10.1016/j.urology.2009.12.022
  3. Van Herzeele C, Walle JV, Dhondt K, Juul KV. Recent advances in managing and understanding enuresis. F1000Res 2017;6:1881.
  4. Arda E, Cakiroglu B, Thomas DT. Primary nocturnal enuresis: a review. Nephrourol Mon 2016;8:e35809.
  5. Neveus T, Lackgren G, Tuvemo T, Stenberg A. Osmoregulation and desmopressin pharmacokinetics in enuretic children. Pediatrics 1999;103:65-70. https://doi.org/10.1542/peds.103.1.65
  6. Lee GK, Chung JM, Lee SD. First-morning urine osmolality and nocturnal enuresis in children: a single-center prospective cohort study. Investig Clin Urol 2023;64:501-9. https://doi.org/10.4111/icu.20220377
  7. Pagana KD, Pagana TJ. Mosby's manual of diagnostic and laboratory tests. 7th ed. Elsevier Health Sciences; 2017.
  8. Eller DA, Homsy YL, Austin PF, Tanguay S, Cantor A. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis. Scand J Urol Nephrol Suppl 1997;183:41-5.
  9. Kawauchi A, Watanabe H, Miyoshi K. Early morning urine osmolality in nonenuretic and enuretic children. Pediatr Nephrol 1996;10:696-8. https://doi.org/10.1007/s004670050191
  10. Steffens J, Netzer M, Isenberg E, Alloussi S, Ziegler M. Vasopressin deficiency in primary nocturnal enuresis: results of a controlled prospective study. Eur Urol 1993;24:366-70. https://doi.org/10.1159/000474330
  11. Eggert P, Kuhn B. Antidiuretic hormone regulation in patients with primary nocturnal enuresis. Arch Dis Child 1995;73:508-11. https://doi.org/10.1136/adc.73.6.508
  12. Abdovic S, Cuk M, Hizar I, Milosevic M, Jerkovic A, Saraga M. Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis. Int Urol Nephrol 2021;53:1529-34. https://doi.org/10.1007/s11255-021-02843-5
  13. Dehoorne JL, Raes AM, van Laecke E, Hoebeke P, Vande Walle JG. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion. J Urol 2006;176:749-53. https://doi.org/10.1016/S0022-5347(06)00297-7
  14. Sozubir S, Ergun G, Celik A, Ulman I, Avanoglu A. The influence of urine osmolality and other easily detected parameters on the response to desmopressin in the management of monosymptomatic nocturnal enuresis in children. Minerva Urol Nefrol 2006;58:207-12.
  15. Leech SC, McHugh K, Sullivan PB. Evaluation of a method of assessing faecal loading on plain abdominal radiographs in children. Pediatr Radiol 1999;29:255-8. https://doi.org/10.1007/s002470050583
  16. Unuvar T, Sonmez F. The role of urine osmolality and ions in the pathogenesis of primary enuresis nocturna and in the prediction of responses to desmopressin and conditioning therapies. Int Urol Nephrol 2005;37:751-7.
  17. Folwell AJ, Macdiarmid SA, Crowder HJ, Lord AD, Arnold EP. Desmopressin for nocturnal enuresis: urinary osmolality and response. Br J Urol 1997;80:480-4. https://doi.org/10.1046/j.1464-410X.1997.00360.x
  18. Medel R, Dieguez S, Brindo M, Ayuso S, Canepa C, Ruarte A, et al. Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin. Br J Urol 1998;81 Suppl 3:46-9.
  19. Neveus T, Eggert P, Evans J, Macedo A, Rittig S, Tekgul S, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children's Continence Society. J Urol 2010;183:441-7. https://doi.org/10.1016/j.juro.2009.10.043
  20. Vande Walle J, Rittig S, Bauer S, Eggert P, Marschall-Kehrel D, Tekgul S, et al. Practical consensus guidelines for the management of enuresis. Eur J Pediatr 2012;171:971-83. https://doi.org/10.1007/s00431-012-1687-7
  21. Akagawa S, Tsuji S, Akagawa Y, Yamanouchi S, Kimata T, Kaneko K. Desmopressin response in nocturnal enuresis showing concentrated urine. Pediatr Int 2020;62:701-4. https://doi.org/10.1111/ped.14201
  22. Kamperis K, Rittig S, Radvanska E, Jorgensen KA, Djurhuus JC. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis. J Urol 2008;180:707-14.
  23. Lee KS, Chang JB, Jang JY, Ko YH, Park YH, Song PH. Role of urine osmolality as a predictor of the effectiveness of combined imipramine and desmopressin in the treatment of monosymptomatic nocturnal enuresis. Yeungnam Univ J Med 2015;32:85-9. https://doi.org/10.12701/yujm.2015.32.2.85